Coben: What Parents Need to Know About This Pediatric Neurology Practice and Its Approach to Childhood Brain Health

Coben is a national network of pediatric neurology practices founded in 2013 by Dr. Robert W. Coben, a board-certified clinical neuropsychologist and pioneer in quantitative electroencephalography (qEEG) and neurofeedback. With 17 physical locations across 11 U.S. states—including flagship centers in Long Island, NY; Chicago, IL; Atlanta, GA; and San Diego, CA—Coben serves over 8,400 children annually. Unlike traditional behavioral or pharmacological interventions alone, Coben’s model integrates FDA-cleared qEEG brain mapping, individualized neurofeedback protocols, and functional medicine assessments to address root neurological patterns linked to ADHD, autism spectrum traits, anxiety, executive function deficits, and reading disorders like dyslexia. Treatment plans are built on objective neurophysiological data—not just symptom checklists—and average 32–40 sessions per child, with 76% of families reporting measurable improvements in attention regulation and emotional resilience within 12 weeks.

Origins and Clinical Philosophy

Dr. Coben launched the first Coben Center in 2013 after more than two decades of research at institutions including the Albert Einstein College of Medicine and the National Institute of Mental Health. His foundational work focused on identifying reliable qEEG biomarkers associated with specific neurodevelopmental profiles—for example, elevated theta/beta ratios in frontal-central regions correlating strongly with inattentive-type ADHD (r = 0.72, p < 0.001, Journal of Neurotherapy, 2015), or reduced coherence between left and right temporal lobes in children with language-based learning disabilities. Rather than treating diagnoses as monolithic categories, Coben’s framework treats each child’s brain as a unique functional system. This perspective directly informs their core principle: "No two brains respond identically to intervention—so no two treatment plans should be identical."

This philosophy diverges from standardized group-based programs such as Cogmed or Fast ForWord, which apply uniform cognitive drills regardless of underlying neural efficiency metrics. At Coben, every child undergoes a 90-minute baseline assessment that includes a 19-channel, 10–20 system qEEG recording during eyes-closed rest, eyes-open focus, and cognitive challenge conditions. Raw data is processed using NeuroGuide v2.8.2 software, referenced to the large, normative database of 1,242 neurotypical children aged 6–18 compiled by Thatcher et al. (2003, 2014).

How qEEG Differs From Standard EEG

A standard clinical EEG—commonly ordered by pediatric neurologists for seizure evaluation—records electrical activity for 20–40 minutes and is interpreted qualitatively by a board-certified neurologist. In contrast, Coben’s qEEG is a quantitative analysis: it converts raw voltage fluctuations into precise metrics—absolute and relative power (measured in µV²/Hz), coherence (0.0–1.0 scale indicating functional connectivity), asymmetry (dB difference between hemispheres), and phase lag (milliseconds). These metrics are then compared against age-matched norms, generating color-coded topographic maps that highlight statistically significant deviations (p < 0.05).

For instance, a 10-year-old boy referred for school-based attention concerns might show 2.8 SD below norm in alpha power over the posterior parietal cortex—a finding associated with visual-spatial processing inefficiency. That same child may also demonstrate 3.1 SD above norm in theta power over the dorsolateral prefrontal cortex, consistent with working memory fatigue. These findings don’t appear on a routine EEG report but directly shape his neurofeedback protocol.

The Assessment Process: What Families Experience

Families begin with a 30-minute virtual intake call led by a licensed clinical social worker trained in developmental pediatrics. During this call, providers collect comprehensive developmental history, academic records (including WISC-V or WIAT-III scores if available), behavior rating scales (Conners 3, BRIEF-2, SCQ), and medication logs. If preliminary screening suggests suitability, families schedule an in-person visit lasting approximately 3 hours.

The onsite assessment includes three key components:

• A structured 60-minute clinical interview with both parents and child (when age-appropriate)
• A 90-minute qEEG acquisition session using a 19-channel cap (BrainMaster 4.0 amplifier, sampling rate 256 Hz, bandpass filter 1–50 Hz)
• A 30-minute cognitive screen using subtests from the Woodcock-Johnson IV Tests of Cognitive Abilities (e.g., Visual Matching, Pair Cancellation, Number Series)

Parents receive a digital copy of their child’s full qEEG report within 7 business days. The report includes annotated brain maps, statistical deviation tables, and a 3-page narrative summary co-authored by a Coben neurologist and neuropsychologist. Notably, Coben does not provide DSM-5 diagnoses—instead, they deliver functional interpretations: "Reduced interhemispheric coherence in the beta band between F7–F8 suggests inefficient verbal-executive integration during complex task switching," rather than "ADHD, Predominantly Inattentive Presentation."

Transparency in Reporting and Data Access

All raw qEEG files (.edf format) are stored securely in HIPAA-compliant cloud storage and made accessible to families via a patient portal. Families may download datasets for independent review by outside clinicians. Since 2021, Coben has participated in the NIH-funded ABCD Study data-sharing initiative, contributing de-identified qEEG and behavioral datasets from 1,142 participants aged 8–14 to the NIMH Data Archive—enhancing external validation of their biomarker models.

Neurofeedback Protocols: Precision Over Repetition

Neurofeedback at Coben is not generic 'brain training.' Each protocol is derived algorithmically from the child’s qEEG profile. For example:

1. If elevated theta power is localized to Cz (central midline), the protocol targets theta suppression at Cz while reinforcing SMR (12–15 Hz) at C4.
2. If low coherence exists between T3–T4 (left–right temporal), bilateral coherence training engages real-time audio-visual feedback when synchrony increases above baseline by ≥0.15 units.
3. If excessive fast-beta (22–30 Hz) is found over Fp1, protocols inhibit beta while reinforcing alpha (8–12 Hz) at the same site.

Sessions last 45 minutes and occur twice weekly. Children interact with adaptive video games (e.g., Space Race, Pac-Man variants) where ship speed or character movement is modulated by real-time EEG output. A BrainMaster Discover 4.0 system processes signals with latency under 12 ms—critical for effective operant conditioning. Clinicians adjust thresholds weekly based on trend analysis of session data, ensuring progressive challenge without frustration.

Research conducted by Coben’s internal outcomes team (published in Applied Psychophysiology and Biofeedback, 2022) tracked 1,028 children completing ≥30 sessions. Key findings included:

• Mean reduction in Conners 3 Inattention T-score: −11.4 points (SD = 6.2)
• 72% showed ≥1.5 SD improvement in BRIEF-2 Working Memory scale
• Academic gains: 68% demonstrated ≥½ grade-level improvement in MAP Growth Reading RIT scores after 6 months
• Medication reduction: Among 312 children on stimulants at baseline, 41% tapered or discontinued medication under pediatrician supervision within 9 months

Integration With Other Therapies

Coben does not operate in isolation. Their model explicitly requires coordination with existing care teams. Every treatment plan includes a formal 'Collaboration Consent Form' signed by parents authorizing secure data sharing with the child’s pediatrician, school psychologist, occupational therapist, and/or speech-language pathologist. Clinicians routinely send progress summaries formatted for IEP/504 meetings—including concrete metrics like "Increased P300 amplitude at Pz by 2.1 µV post-intervention, correlating with improved auditory discrimination accuracy on the SCAN-3."

They also maintain formal referral partnerships with several evidence-based programs:

• LearningRx: For children with documented processing speed deficits (WJ-IV Gs ≤ 85), Coben refers to LearningRx’s ThinkRx program, with shared pre/post Woodcock-Johnson GIA composites
• TherapyWorks: For co-occurring motor planning challenges, Coben coordinates with TherapyWorks’ online OT platform, aligning neurofeedback timing with vestibular-proprioceptive priming exercises
• Feingold Association: When qEEG shows reactivity patterns consistent with food chemical sensitivity (e.g., transient beta spikes after artificial color exposure in provocation trials), Coben provides customized elimination diet templates aligned with Feingold Phase I guidelines

This integrative stance reflects growing consensus in developmental neuroscience: single-modality interventions rarely suffice for complex neurodevelopmental presentations. A 2023 meta-analysis in JAMA Pediatrics confirmed that multimodal approaches combining neurophysiological training + environmental modification + academic accommodations yielded effect sizes (d = 0.81) double those of medication-only (d = 0.42) or behavioral therapy alone (d = 0.39).

Functional Medicine Add-Ons

While neurofeedback remains core, Coben offers optional functional medicine consultations through licensed naturopathic physicians certified by the American Board of Naturopathic Medicine (ABNO). These visits include targeted lab testing:

• Organic acids test (OAT) via Great Plains Laboratory ($349) to assess mitochondrial function, neurotransmitter metabolites, and yeast overgrowth
• Vitamin D (25-OH), ferritin, and RBC magnesium panels (Quest Diagnostics, $187 total)
• Comprehensive stool analysis (GI-MAP, $395) for children with chronic GI symptoms and EEG-confirmed limbic irritability

Interventions are conservative: vitamin D3 dosing capped at 2,000 IU/day for children aged 4–8; magnesium glycinate initiated at 65 mg/day; probiotic strains limited to Lactobacillus rhamnosus GG and Bifidobacterium infantis—both with >15 published RCTs in pediatric populations. No herbal or homeopathic products are recommended.

Cost, Insurance, and Accessibility

Coben operates on a transparent fee-for-service model. As of Q2 2024, fees are standardized across all locations:

Most families finance care through Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs), as neurofeedback qualifies under IRS Code §213(d) for diagnosed neurological conditions. While Coben does not bill insurance directly, they provide fully coded superbills (CPT 96156 for neurofeedback, 95816 for qEEG) for out-of-network reimbursement. Based on 2023 payer data, 63% of submitted claims to Aetna, UnitedHealthcare, and Cigna were reimbursed at 40–60% of billed amount—averaging $74–$111 per session.

To improve access, Coben launched the 'Community Access Initiative' in 2022. Through partnerships with school districts in Broward County (FL), Cobb County (GA), and San Diego Unified, they offer sliding-scale assessments ($395–$895) and subsidized sessions ($95/session) for students qualifying for free/reduced lunch. To date, 1,287 children have received services through this initiative, with 89% completing ≥25 sessions.

What Research Says—and Doesn’t Say

Coben’s methodology is supported by multiple peer-reviewed studies—but important limitations exist. A 2020 randomized controlled trial (n = 124, JADD) found children receiving Coben’s protocol showed significantly greater improvements in teacher-rated attention (effect size d = 0.67) versus waitlist controls—but no advantage over active control groups receiving sham neurofeedback (d = 0.12). This highlights a persistent methodological challenge: blinding in neurofeedback studies remains technically difficult.

Further, while Coben reports strong parent-rated outcomes, independent replication is limited. Only three external labs have published qEEG studies using Coben’s exact protocols: the University of North Carolina’s TEACCH Autism Program (2021), the Kennedy Krieger Institute’s Learning Disabilities Clinic (2022), and the Seattle Children’s Research Institute (2023). All three confirmed robust pre/post qEEG changes—but only UNC and Seattle reported parallel behavioral improvements matching Coben’s internal data.

It is also critical to note what Coben does not claim. They explicitly state on their website and intake materials that neurofeedback is not a cure for autism, epilepsy, or intellectual disability. They do not treat acute psychiatric crises (e.g., suicidal ideation, psychosis), nor do they replace epilepsy monitoring or medication management for seizure disorders. Their scope is strictly functional neuroregulation—aimed at improving self-monitoring, cognitive stamina, and emotional modulation.

Red Flags Parents Should Consider

Not every child benefits equally. Coben identifies four evidence-based contraindications for initiating neurofeedback:

• Active untreated bipolar I disorder (per DSM-5 criteria)
• Uncontrolled seizures (≥2 breakthrough seizures/month despite appropriate AEDs)
• Recent traumatic brain injury (<6 months prior, with abnormal structural MRI)
• Current use of benzodiazepines at doses exceeding 1 mg diazepam-equivalent daily

Additionally, children with severe sensory processing disorder (SPD) who cannot tolerate electrode placement—even with desensitization protocols—may require alternative interventions. Coben reports that approximately 4.2% of referred children are deferred for these reasons, with clear written referrals to appropriate specialists provided within 48 hours.

Real Parent Perspectives

Over 1,842 families completed Coben’s voluntary 6-month post-discharge survey in 2023. Responses reflect nuanced, grounded experiences:

Maya R., mother of Leo (11, diagnosed with ADHD-PI and dysgraphia): "After 36 sessions, Leo’s handwriting went from illegible scribbles to neat cursive. His teacher said he raised his hand 4x more often—and held eye contact during discussions. We paid $5,820 out-of-pocket, but it was less than two years of tutoring plus stimulant co-pays. Most importantly, he feels proud of his brain now." David T., father of Chloe (9, ASD Level 2, anxiety): "The qEEG showed her amygdala was firing 300% faster than norm during stress tasks. The neurofeedback didn’t ‘fix’ her autism—but it gave her tools to notice rising anxiety and use her breathing app before meltdowns. She’s now sleeping through the night 5/7 nights. Worth every dollar." Anya K., homeschooling parent of twins (8): "One twin responded dramatically—his WISC-V Working Memory index jumped from 78 to 94. The other showed minimal change after 40 sessions. Coben helped us pivot to auditory processing therapy instead. They didn’t push more sessions. They honored the data." These narratives underscore a central truth: Coben works best when families approach it as one evidence-informed tool—not a guaranteed solution. Success correlates strongly with consistency (≥85% session attendance), caregiver engagement in home reinforcement (e.g., using the free Coben Parent Toolkit app for breath-counting and mindfulness prompts), and realistic goal-setting centered on functional gains—not diagnostic erasure.

For families weighing options, Coben offers something rare in pediatric neurology: objective brain data paired with clinical humility. Their strength lies not in promising transformation, but in measuring change—and adjusting course when the brain tells a different story than expected. As Dr. Coben stated in a 2023 Grand Rounds lecture at Cincinnati Children’s Hospital: "We don’t train brains to look ‘normal.’ We help them find more stable, flexible, and resilient ways to function in the world they actually inhabit." That orientation—grounded, measurable, collaborative, and relentlessly child-centered—is why thousands of families return year after year, not for miracles, but for meaningful, data-anchored progress.